Loss of the eukaryotic initiation factor 3f in melanoma

Molecular Carcinogenesis

Volumn 47, Issue 10, 2008, Pages 806-813

  Doldan, Adriana ^a   Chandramouli, Anupama ^a   Shanas, Reneé ^a   Bhattacharyya, Achyut ^a   Leong, Stanley P L ^b   Nelson, Mark A ^a   Shi, Jiaqi ^a,c,d  

^a UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF ARIZONA   (United States)

^d UNIVERSITY OF ARIZONA   (United States)

Author keywords

Apoptosis; Eukaryotic initiation factor 3f; Loss of heterozygosity; Melanoma

Indexed keywords

INITIATION FACTOR 3; INITIATION FACTOR 3F; UNCLASSIFIED DRUG; PRIMER DNA;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CLINICAL ARTICLE; GENE; GENE LOCATION; GENE LOSS; GENE MUTATION; GENE NUMBER; GENETIC POLYMORPHISM; HETEROZYGOSITY LOSS; HUMAN; IMMUNOHISTOCHEMISTRY; INITIATION FACTOR 3F GENE; MELANOMA; MICROSATELLITE MARKER; MOLECULAR BIOLOGY; PREVALENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; CHROMOSOME 11; CHROMOSOME MAP; GENETICS; MUTATION; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION;

EUKARYOTA;

BASE SEQUENCE; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 11; DNA PRIMERS; EUKARYOTIC INITIATION FACTOR-3; HUMANS; IMMUNOHISTOCHEMISTRY; LOSS OF HETEROZYGOSITY; MELANOMA; MUTATION; POLYMERASE CHAIN REACTION;

EID: 52649087857     PISSN: 08991987     EISSN: 10982744     Source Type: Journal    
DOI: 10.1002/mc.20436     Document Type: Article

References (30)

1. Grange F. Epidemiology of cutaneous melanoma: Descriptive data in France and Europe. Ann Dermatol Venereol 2005;132:975-982.
2. Lee ML, Tomsu K, Von Eschen KB. Duration of survival for disseminated malignant melanoma: Results of a meta-analysis. Melanoma Res 2000;10:81-92.
3. Perlis C, Herlyn M. Recent advances in melanoma biology. Oncologist 2004;9:182-187.
4. Sabel MS, Sondak VK. Pros and cons of adjuvant interferon in the treatment of melanoma. Oncologist 2003;8:451-458.
5. Flaherty LE, Gadgeel SM. Biochemotherapy of melanoma. Semin Oncol 2002;29:446-455.
6. Zhang L, Pan X, Hershey JW. Individual overexpression of five subunits of human translation initiation factor elF3 promotes malignant transformation of immortal fibroblast cells. J Biol Chem 2007;282:5790-5800.
7. Rosenwald IB. The role of translation in neoplastic transformation from a pathologist's point of view. Oncogene 2004;23:3230-3247.
8. Avdulov S, Li S, Michalek V, et al. Activation of translation complex elF4F is essential for the genesis and maintenance of the malignant phenotype in human mammary epithelial cells. Cancer Cell 2004;5:553-563.
9. Mamane Y, Petroulakis E, Rong L, et al. elF4E - From translation to transformation. Oncogene 2004;23:3172-3179.
10. Donze O, Jagus R, Koromilas AE, et al. Abrogation of translation initiation factor elF-2 phosphorylation causes malignant transformation of NIH 3T3 cells. EMBO J 1995;14:3828-3834.
11. Pestova TV, Hellen CU. Functions of eukaryotic factors in initiation of translation. Cold Spring Harb Symp Quant Biol 2001;66:389-396.
12. Doldan A, Chandramouli A, Shanas R, et al. Loss of the eukaryotic initiation factor 3f in pancreatic cancer. Mol Carcinog 2008;47:235-244.
13. Lin L, Holbro T, Alonso G, et al. Molecular interaction between human tumor marker protein p150, the largest subunit of elF3, and intermediate filament protein K7. J Cell Biochem 2001;80:483-490.
14. Pincheira R, Chen Q, Zhang JT. Identification of a 170-kDa protein over-expressed in lung cancers. Br J Cancer 2001;84:1520-1527.
15. Rothe M, Ko Y, Albers P, et al. Eukaryotic initiation factor 3 p110 mRNA is overexpressed in testicular seminomas. Am J Pathol 2000;157:1597-1604.
16. Nupponen NN, Porkka K, Kakkola L, et al. Amplification and overexpression of p40 subunit of eukaryotic translation initiation factor 3 in breast and prostate cancer. Am J Pathol 1999;154:1777-1783.
17. Mayeur GL, Hershey JW. Malignant transformation by the eukaryotic translation initiation factor 3 subunit p48 (elF3e). FEBS Lett 2002;514:49-54.
18. Marchetti A, Buttitta F, Miyazaki S, et al. Int-6, a highly conserved, widely expressed gene, is mutated by mouse mammary tumor virus in mammary preneoplasia. J Virol 1995;69:1932-1938.
19. Marchetti A, Buttitta F, Pellegrini S, et al. Reduced expression of INT-6/elF3-p48 in human tumors. Int J Oncol 2001;18:175-179.
20. Shi J, Kahle A, Hershey JW, et al. Decreased expression of eukaryotic initiation factor 3f deregulates translation and apoptosis in tumor cells. Oncogene 2006;25:4923-4936.
21. Shi J, Feng Y, Goulet AC, et al. The p34cdc2-related cyclin-dependent kinase 11 interacts with the p47 subunit of eukaryotic initiation factor 3 during apoptosis. J Biol Chem 2003;278:5062-5071.
22. Trovato M, Ulivieri A, Dominici R, et al. Clinico-pathological significance of cell-type-specific loss of heterozygosity on chromosome 7q21: Analysis of 318 microdissected thyroid lesions. Endocr Relat Cancer 2004;11:365-376.
23. Livak KJ, Flood SJ, Marmaro J, et al. Oligonucleotides with fluorescent dyes at opposite ends provide a quenched probe system useful for detecting PCR product and nucleic acid hybridization. PCR Methods Appl 1995;4:357-362.
24. User bulletin #2 Relative Quantitation of gene Expression (P/N 4303859), Applied Biosystems. 1997.
25. Iwamoto M, Banerjee D, Menon LG, et al. Overexpression of E2F-1 in lung and liver metastases of human colon cancer is associated with gene amplification. Cancer Biol Ther 2004;3:395-399.
26. Coupry I, Monnet L, Attia AA, et al. Analysis of CBP (CREBBP) gene deletions in Rubinstein-Taybi syndrome patients using real-time quantitative PCR. Hum Mutat 2004;23:278-284.
27. Parrella P, Sidransky D, Merbs SL. Allelotype of posterior uveal melanoma: Implications for a bifurcated tumor progression pathway. Cancer Res 1999;59:3032-3037.
28. Tomlinson IP, Beck NE, Bodmer WF. Allele loss on chromosome 11q and microsatellite instability in malignant melanoma. Eur J Cancer 1996;32A:1797-1802.
29. Miyazaki S, Imatani A, Ballard L, et al. The chromosome location of the human homolog of the mouse mammary tumor-associated gene INT6 and its status in human breast carcinomas. Genomics 1997;46:155-158.
30. Guo Y, Harris RB, Rosson D, et al. Functional analysis of human ornithine decarboxylase alleles. Cancer Res 2000;60:6314-6317.